Scarica l'app Stockscreener
2.97
4.21%
0.12
Pre-mercato:
2.85
-0.12
-4.04%
Precedente Chiudi:
$2.85
Aprire:
$2.9
Volume 24 ore:
4.70M
Relative Volume:
1.04
Capitalizzazione di mercato:
$378.85M
Reddito:
$4.21M
Utile/perdita netta:
$-97.67M
Rapporto P/E:
-3.1935
EPS:
-0.93
Flusso di cassa netto:
$-70.76M
1 W Prestazione:
+0.68%
1M Prestazione:
+11.24%
6M Prestazione:
-40.48%
1 anno Prestazione:
-18.85%
Intervallo 1D:
$2.86
$3.01
Intervallo di 1 settimana:
$2.82
$3.04
Portata 52W:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
Nome
Absci Corp
Settore
Industria
Telefono
(360) 949-1041
Indirizzo
18105 SE MILL PLAIN BLVD, VANCOUVER
Confronta ABSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.97 | 411.05M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-01-22 | Iniziato | Needham | Buy |
| 2024-10-02 | Iniziato | Guggenheim | Buy |
| 2024-07-03 | Iniziato | Morgan Stanley | Overweight |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Iniziato | Truist | Buy |
| 2022-03-02 | Ripresa | Cowen | Market Perform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-11-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-08-16 | Iniziato | BofA Securities | Neutral |
| 2021-08-16 | Iniziato | Cowen | Market Perform |
| 2021-08-16 | Iniziato | Credit Suisse | Outperform |
| 2021-08-16 | Iniziato | Stifel | Hold |
Mostra tutto
Absci Corp Borsa (ABSI) Ultime notizie
AbSci Corp options imply significant post-earnings price movement. - AInvest
Absci Corp (ABSI) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges By GuruFocus - Investing.com Canada
Absci Corporation: Navigating Near-Term Challenges to Unlock Long-Term Growth in AI-Driven Biotech - AInvest
Absci Corporation Reports Q2 2025 Financial Results - TipRanks
Absci Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Absci’s Q2 2025 results disappoint with revenue miss By Investing.com - Investing.com South Africa
Earnings call transcript: Absci’s Q2 2025 results disappoint with revenue miss - Investing.com
Absci Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Absci earnings missed by $0.03, revenue fell short of estimates - Investing.com
Absci Corp SEC 10-Q Report - TradingView
Absci reports Q2 EPS (24c), consensus (21c) - TipRanks
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results - GlobeNewswire
Absci Corp (ABSI) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Absci (ABSI) Expected to Announce Earnings on Tuesday - MarketBeat
Historical volatility pattern of Absci Corporation visualized7-Day Equity Return Range Forecast Model - Newser
Absci Corporation (NASDAQ:ABSI) Receives $8.28 Consensus Price Target from Analysts - MarketBeat
Absci Corp expected to post a loss of 21 cents a shareEarnings Preview - TradingView
Absci Corporation (NASDAQ:ABSI) Receives $8.28 Consensus Price Target from Brokerages - Defense World
Absci Corporation Stock (ABSI) Opinions on $50 Million Public Offering and AI Collaboration - Quiver Quantitative
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Absci, Almirall Expand Collaboration to Include Second Dermatology Target - MarketScreener
Absci (NASDAQ:ABSI) Upgraded to Hold at Wall Street Zen - MarketBeat
Almirall and Absci Corporation Expand Ai Drug Creation Collaboration Adding A Second Dermatology Target - MarketScreener
Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target - GlobeNewswire
AI Drug Discovery Breakthrough: Absci Lands Second Target After Successfully Designing Undruggable Molecule - Stock Titan
Earnings Preview: Absci Corp to Report Financial Results Post-market on August 12 - 富途牛牛
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Officer Busch Andreas - 富途牛牛
TR | OpenAI4o Maintains Absci Corp(ABSI.US) With Hold Rating, Maintains Target Price $3 - 富途牛牛
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Director VAN HOUTEN FRANS - 富途牛牛
Does Absci Corporation stock perform well during market downturnsAchieve rapid financial growth with smart picks - Jammu Links News
What analysts say about Absci Corporation stockStrong return on assets - Jammu Links News
Andreas Busch Buys 50,000 Shares of Absci Corporation (NASDAQ:ABSI) Stock - MarketBeat
What are analysts’ price targets for Absci Corporation in the next 12 monthsReal Time Tracker For Fast Growth - Jammu Links News
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 - The Manila Times
Absci AI Drug Discovery Pioneer Announces Q2 2025 Earnings Date, Conference Details - Stock Titan
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.
Absci Corporation (NASDAQ:ABSI) Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium - MSN
Absci Corporation (NASDAQ:ABSI) Shares Acquired by Royce & Associates LP - MarketBeat
ARK Investment Management LLC Boosts Stock Position in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci Corporation Stock (ABSI) Opinions on $50 Million Public Offering - Quiver Quantitative
Absci Corp's Busch Andreas Buys 50K Shares at $3.04 on 2025-07-28 - AInvest
Absci Corporation Shows Early Signs of Technical StrengthMarket Entry and Exit Point Tips From Traders - metal.it
Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Adds Absci and Iridium - AInvest
Morgan Stanley Has Lowered Expectations for Absci (NASDAQ:ABSI) Stock Price - MarketBeat
Will Absci Corporation Sustain Its Chart BreakoutDaily Volume Spike Trading Signals Detected - metal.it
Absci announces proposed public offering of common stock - MSN
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
Pier 88 Investment Partners LLC Has $762,000 Stock Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Cathie Wood’s ARK ETF adjusts portfolio, buys ABSCI, sells CRISPR - Investing.com
Absci Prices $50 Mln Public Offering To Advance AI-Driven Drug Programs - Nasdaq
Absci Corp Azioni (ABSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):